Dow Up 0.35% Nasdaq Down 0.02%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
345.28 1.51(0.44%) Aug 20, 4:00PM EDT
Prev Close:346.79
Open:345.22
Bid:308.00 x 100
Ask:372.17 x 200
1y Target Est:353.28
Beta:0.86
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:344.09 - 349.38
52wk Range:233.06 - 353.05
Volume:352,646
Avg Vol (3m):826,267
Market Cap:34.66B
P/E (ttm):98.99
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.44%34.66B
AMGN100.78B
NVS214.96B
RHHBY247.66B

Key Statistics

Forward P/E (1 yr):28.19
P/S (ttm):13.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.15
Quarterly EPS Est (Sep-14) :2.58
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.59

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback